FDA notifications.  Lamivudine/zidovudine tab tentatively approved.
D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004338:Drug Combinations; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage; D013607:Tablets; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine / Q000008:administration & dosage
D004338:Drug Combinations; D018894:Reverse Transcriptase Inhibitors; D013607:Tablets; D019259:Lamivudine; D015215:Zidovudine